posted on 2019-06-05, 00:00authored bySebastian Schieferdecker, Gulimila Shabuer, Anne-Catrin Letzel, Barbara Urbansky, Mie Ishida-Ito, Keishi Ishida, Michael Cyrulies, Hans-Martin Dahse, Sacha Pidot, Christian Hertweck
Metabolic profiling
and genome mining revealed that anaerobic bacteria
have the potential to produce acyloin natural products. In addition
to sattazolin A and B, three new sattazolin congeners and a novel
acyloin named clostrocyloin were isolated from three strains of Clostridium beijerinckii, a bacterium used for industrial
solvent production. Bioactivity profiling showed that the sattazolin
derivatives possess antimicrobial activities against mycobacteria
and pseudomonads with only low cytotoxicity. Clostrocyloin was found
to be mainly active against fungi. The thiamine diphosphate (ThDP)-dependent
sattazolin-producing synthase was identified in silico and characterized both in vivo and in in
vitro enzyme assays. A related acyloin synthase from the
clostrocyloin producer was shown to be responsible for the production
of the acyloin core of clostrocyloin. The biotransformation experiments
provided first insights into the substrate scope of the clostrocyloin
synthase and revealed biosynthetic intermediates.